Science Explorer Back to mapMap
Discussion
Researcher · Kenyon College · United States

Leigh Ann Ellison

Leigh Ann Ellison publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Peptidase Inhibition and Analysis, Prostate Cancer Treatment and Research and PARP inhibition in cancer therapy.

OpenAlex
World rank
#7,710,297
of 7,710,434 ranked researchers
Rank in United States
#1,627,030
of 1,627,098
Works
788
Citations
0
h-index
0
i10-index 0Top 100% in Oncology
Leigh Ann Ellison

What does Leigh Ann Ellison research?

Leigh Ann Ellison's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (12%), Materials Science (10%).

Health Sciences: 497 works · 63.1% of their workMedicine: 497 works · 63.1% of their workOncology: 281 works · 35.6% of their workPulmonary and Respiratory Medicine: 143 works · 18.1% of their workSurgery: 74 works · 9.4% of their workLife Sciences: 170 works · 21.6% of their workBiochemistry, Genetics and Molecular Biology: 94 works · 11.9% of their workMolecular Biology: 94 works · 11.9% of their workPharmacology, Toxicology and Pharmaceutics: 76 works · 9.7% of their workPharmaceutical Science: 76 works · 9.7% of their workPhysical Sciences: 81 works · 10.3% of their workMaterials Science: 81 works · 10.3% of their workPolymers and Plastics: 81 works · 10.3% of their workEverything else: 39 works · 5.0% of their workTHEIR WORKLeigh Ann Ellison788works
Life Sciences22%Physical Sciences10%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine49763.1%
    1. Biochemistry, Genetics and Molecular Biology9411.9%
    2. Pharmacology, Toxicology and Pharmaceutics769.7%
    1. Materials Science8110.3%
  4. Everything else395.0%
  1. 1Oncology36% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Molecular Biology12% of their works
  4. 4Polymers and Plastics10% of their works
  5. 5Pharmaceutical Science10% of their works
  6. 6Surgery9% of their works

Research topics

Which keywords describe Leigh Ann Ellison's research?

The keywords of their largest research topics: Cancer Therapy, Fibroblast Activation Protein, Tumor Microenvironment, Androgen Receptor, Prostate Cancer, BRCA Mutation, PARP Inhibitors and Deuterium.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer Therapy7742 topics
  2. Fibroblast Activation Protein4571 topic
  3. Tumor Microenvironment4571 topic
  4. Androgen Receptor3971 topic
  5. Prostate Cancer3971 topic
  6. BRCA Mutation3171 topic
  7. PARP Inhibitors3171 topic
  8. Deuterium2131 topic
  9. Drug Discovery2131 topic
  10. Plasticizers2131 topic
  11. Poly(vinyl chloride)2131 topic
  12. Heparin-Induced Thrombocytopenia1851 topic
  13. Thrombosis1851 topic
  14. PTPN111321 topic
  15. Protein Tyrosine Phosphatases1321 topic
  16. Mammalian Cells961 topic
  17. Recombinant Protein961 topic

Where does Leigh Ann Ellison work?

Leigh Ann Ellison's main affiliation in the publication record is Kenyon College, United States.

How many publications and citations does Leigh Ann Ellison have?

OpenAlex counts 788 works and 0 citations for Leigh Ann Ellison, an h-index of 0, ranking #7,710,297 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Leigh Ann Ellison. Posts are plain text and can be reported.